Chugai Pharmaceutical Co., Ltd Stock

Equities

4519

JP3519400000

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-06-24 EDT 5-day change 1st Jan Change
5,358 JPY +3.90% Intraday chart for Chugai Pharmaceutical Co., Ltd +8.42% +0.30%

Financials

Sales 2024 * 1,089B 6.83B 9.33B Sales 2025 * 1,130B 7.09B 9.69B Capitalization 8,485B 53.2B 72.72B
Net income 2024 * 346B 2.17B 2.96B Net income 2025 * 366B 2.3B 3.14B EV / Sales 2024 * 7.02 x
Net cash position 2024 * 839B 5.26B 7.19B Net cash position 2025 * 1,085B 6.8B 9.3B EV / Sales 2025 * 6.55 x
P/E ratio 2024 *
24.6 x
P/E ratio 2025 *
23.2 x
Employees 7,604
Yield 2024 *
1.64%
Yield 2025 *
1.72%
Free-Float 38.08%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Chugai Pharmaceutical Co., Ltd

1 day+3.90%
1 week+8.42%
Current month+12.07%
1 month+12.85%
3 months-8.41%
6 months+0.17%
Current year+0.30%
More quotes
1 week
4 943.00
Extreme 4943
5 359.00
1 month
4 572.00
Extreme 4572
5 359.00
Current year
4 572.00
Extreme 4572
6 697.00
1 year
3 767.00
Extreme 3767
6 697.00
3 years
3 191.00
Extreme 3191
6 697.00
5 years
2 296.67
Extreme 2296.6667
6 697.00
10 years
932.33
Extreme 932.3333
6 697.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 87-03-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 79 15-02-28
Director/Board Member 66 84-03-31
Director/Board Member 65 19-02-28
More insiders
Date Price Change Volume
24-06-24 5,358 +3.90% 3 263 600
24-06-21 5,157 +0.29% 2,537,000
24-06-20 5,142 -0.21% 1,703,100
24-06-19 5,153 +2.06% 2,556,200
24-06-18 5,049 +2.17% 1,888,200

Delayed Quote Japan Exchange, June 24, 2024 at 02:00 am

More quotes
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%). Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
5,157 JPY
Average target price
5,932 JPY
Spread / Average Target
+15.03%
Consensus